Primary hypertriglyceridemia in children and adolescents

Area of Science:

• Pediatric Endocrinology
• Lipid Metabolism Disorders
• Genetics

Background:

• Primary hypertriglyceridemia (HyperTG) arises from genetic defects affecting triglyceride synthesis and metabolism.
• While often adult-onset, some HyperTG forms manifest in adolescence, exacerbated by factors like obesity and insulin resistance.
• Clinical signs may include eruptive xanthomas, with very high triglyceride levels potentially occurring alongside other lipid abnormalities.

Purpose of the Study:

• To review the causes of primary HyperTG in pediatric populations.
• To discuss clinical presentations, complications (pancreatitis, premature cardiovascular disease), and management strategies.
• To highlight novel therapies under development for pediatric HyperTG.

Main Methods:

• Literature review of primary hypertriglyceridemia in children and adolescents.
• Analysis of clinical findings, diagnostic criteria, and associated risks.
• Examination of current and emerging therapeutic interventions.

Main Results:

• Primary HyperTG in youth results from genetic defects, with potential early onset influenced by metabolic factors.
• Associated risks include recurrent pancreatitis and premature cardiovascular disease.
• Lifestyle modifications are the primary treatment, with pharmacologic options available for specific cases.

Conclusions:

• Primary HyperTG in children and adolescents requires timely diagnosis and comprehensive management.
• Understanding genetic causes and clinical manifestations is key to mitigating severe complications.
• Ongoing research into novel therapies offers future treatment possibilities for this pediatric population.